Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR

  1. Weisel, K.
  2. Mateos, M.-V.
  3. Gay, F.
  4. Delforge, M.
  5. Cook, G.
  6. Szabo, Z.
  7. Desgraz, R.
  8. DeCosta, L.
  9. Moreau, P.
Journal:
Leukemia

ISSN: 1476-5551,  0887-6924

Year of publication: 2021

Volume: 35

Issue: 6

Pages: 1732-1744

Type: Article

DOI: 10.1038/S41375-020-01049-5 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus